Mitochondrial E3 ubiquitin ligase 1 (MUL1) as a novel therapeutic target for diseases associated with mitochondrial dysfunction.
Calle X, Garrido-Moreno V, Lopez-Gallardo E, Norambuena-Soto I, Martínez D, Peñaloza-Otárola A, Troncossi A, Guerrero-Moncayo A, Ortega A, Maracaja-Coutinho V, Parra V, Chiong M, Lavandero S.
Calle X, et al. Among authors: lavandero s.
IUBMB Life. 2022 Sep;74(9):850-865. doi: 10.1002/iub.2657. Epub 2022 Jun 21.
IUBMB Life. 2022.
PMID: 35638168
Free article.
Review.